Literature DB >> 11107050

Alternatively spliced MDM2 transcripts in human breast cancer in relation to tumor necrosis and lymph node involvement.

M Hori1, J Shimazaki, S Inagawa, M Itabashi, M Hori1.   

Abstract

Several short forms of alternatively spliced Murine double minute 2 (MDM2) transcripts have recently been shown to correlate with high-grade malignancy in a number of human tumors. We examined the frequency of splice variants and their correlation with clinicopathological features in 60 cases of human breast cancer. Seven short forms coexpressed with wild-type mRNA were detected by nested RT-PCR. Sequencing of all the MDM2 variants demonstrated mRNA splicing which disrupted not only the conserved p53-binding domain but also, further towards the carboxy-terminus, the conserved nuclear localization sequence and/or the acidic and zinc finger domains. There was no significant correlation between the coexpression of splice variants and tumor size, histologic type or hormone (estrogen and progesterone) receptor status. However, cases with spliced MDM2 transcripts tended to be of a more aggressive type with axillary lymph node involvement and extensive necrosis in the tumors. Although the functional significance of MDM2 variants remains obscure, we anticipate that these variants will be confirmed as a novel prognostic marker in human breast cancer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11107050     DOI: 10.1046/j.1440-1827.2000.01119.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  7 in total

1.  Stress-induced isoforms of MDM2 and MDM4 correlate with high-grade disease and an altered splicing network in pediatric rhabdomyosarcoma.

Authors:  Aishwarya G Jacob; Dennis O'Brien; Ravi K Singh; Daniel F Comiskey; Robert M Littleton; Fuad Mohammad; Jordan T Gladman; Maria C Widmann; Selvi C Jeyaraj; Cheryl Bolinger; James R Anderson; Donald A Barkauskas; Kathleen Boris-Lawrie; Dawn S Chandler
Journal:  Neoplasia       Date:  2013-09       Impact factor: 5.715

2.  The splicing factor FUBP1 is required for the efficient splicing of oncogene MDM2 pre-mRNA.

Authors:  Aishwarya G Jacob; Ravi K Singh; Fuad Mohammad; Thomas W Bebee; Dawn S Chandler
Journal:  J Biol Chem       Date:  2014-05-05       Impact factor: 5.157

3.  Subcellular localization of Mdm2 expression and prognosis of breast cancer.

Authors:  Hyung Seok Park; Ji Min Park; Seho Park; Junghoon Cho; Seung Il Kim; Byeong-Woo Park
Journal:  Int J Clin Oncol       Date:  2013-11-29       Impact factor: 3.402

4.  Investigation of FJ 194940.1 gene alternative splicing in colon cancer and its association with clinicopathological parameters.

Authors:  Malwina Bartczak-Tomczyk; Aleksandra Sałagacka; Marek Mirowski; Ewa Balcerczak
Journal:  Exp Ther Med       Date:  2011-11-09       Impact factor: 2.447

5.  Splicing factor SRSF1 negatively regulates alternative splicing of MDM2 under damage.

Authors:  Daniel F Comiskey; Aishwarya G Jacob; Ravi K Singh; Aixa S Tapia-Santos; Dawn S Chandler
Journal:  Nucleic Acids Res       Date:  2015-04-06       Impact factor: 16.971

6.  Stress-induced alternative splice forms of MDM2 and MDMX modulate the p53-pathway in distinct ways.

Authors:  Aishwarya G Jacob; Ravi K Singh; Daniel F Comiskey; Matthew F Rouhier; Fuad Mohammad; Thomas W Bebee; Dawn S Chandler
Journal:  PLoS One       Date:  2014-08-08       Impact factor: 3.240

7.  A novel mouse model of rhabdomyosarcoma underscores the dichotomy of MDM2-ALT1 function in vivo.

Authors:  D F Comiskey; A G Jacob; B L Sanford; M Montes; A K Goodwin; H Steiner; E Matsa; A S Tapia-Santos; T W Bebee; J Grieves; K La Perle; P Boyaka; D S Chandler
Journal:  Oncogene       Date:  2017-09-11       Impact factor: 9.867

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.